KMSTF

Header iconKMSTF Comparison
Open Charts KMSTFBanner chart's image
KADIMASTEM
Price$5.06
Change-$0.04 (-0.78%)
Volume$150
Capitalization38.64M
KMSTF Comparison Chart in %
Loading...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.89B. The market cap for tickers in the group ranges from 58 to 100.34B. VRTX holds the highest valuation in this group at 100.34B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 35%. NDTP experienced the highest price growth at 1,681%, while ATYR experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 86%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 82
Price Growth Rating: 57
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: -22 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (KMSTF: $5.06)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMSTF’s FA Score shows that 0 FA rating(s) are green while.

  • KMSTF’s FA Score: 0 green, 5 red.

Price Growth

KMSTF (@Biotechnology) experienced а 0.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
KMSTF
Capitalization38.6M
EBITDA-9.53M
Gain YTD-20.987
P/E RatioN/A
Revenue0
Total CashN/A
Total DebtN/A
TECHNICAL ANALYSIS
Technical Analysis
KMSTF
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
7%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
5%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHPPY13.37N/A
N/A
Signify N.V.
PZRIF11.41N/A
N/A
Pizza Pizza Royalty Corp.
WPLCF15.17-0.33
-2.13%
WISE PLC
BIOQ39.00-1.01
-2.52%
BIOQUAL, Inc.
AMMX0.09N/A
-4.18%
AmeraMex International Inc.

KMSTF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
+0.73%
ZVRA - KMSTF
30%
Poorly correlated
+0.41%
ACUT - KMSTF
28%
Poorly correlated
N/A
SRZN - KMSTF
28%
Poorly correlated
-0.78%
BLRX - KMSTF
24%
Poorly correlated
+3.73%
More